Fusidic Acid 2 Percent Clotrimazole 1 Percent Clobetasol 0 Point 05 Percent oint 10gm,Gabapentin 30
Indian Army
Bid Publish Date
05-Apr-2025, 1:30 pm
Bid End Date
26-Apr-2025, 2:00 pm
EMD
₹9,435
Location
Progress
RAQuantity
579870
Indian Army announces a tender for Acyclovir 200 mg Tab, Acenocoumarol 1 mg Tab, TAB DIVALPROX 1000MG, Fluvoxamine 50 mg Cap, Syrup Terbutaline sulphate 1 point 25 mg plus Bromhexine HCL 4 mg plus Guaiphenesin 50 mg per 5 ml bootle of 100 ml, Isosorbide Mononitrate 20 mg Tab, Risperidone 4 mg Tab, Rivaroxaban 20 mg Tab, Tacrolimus 0 point 5 mg Cap, Tab Methotrexate10 mg, Tab Melatonin 3 mg, Clobazam 5 mg Tab, Tab Donepezil 10mg, Tab Dutasteride 0 point mg, Gabapentin 300 mg Cap, Terbinafine 1 percentage cream Tube of 10 gm, Nasal Decongestant adult drops Xylometazoline HCL 0 point 1 percentage w oblique v nasal drop bottle of 10 ml, Moxifloxacin Eye ointment 0 point 5 percentage w oblique w coma 5g, Tiotropium Bromide 9 mcg 120 metered doses oblique unit coma Inhaler, Tobramycin 0 point 3 percentage bott of 5 ml, Rifaximin 550mg Cap, Tab Bempedoic Acid 160 Mg in KOLKATA, WEST BENGAL. Quantity: 579870. Submission Deadline: 26-04-2025 14: 00: 00. Last date to apply is approaching fast!
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
Indian Army
Indian Army
Indian Army
Dg Armed Forces Medical Service
KANNUR, KERALA
Indian Navy
VISAKHAPATNAM, ANDHRA PRADESH
Tender Results
Loading results...
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | Acyclovir 200 mg Tab | Acyclovir 200 mg Tab | 14,200 | no | consignee2dglp | 30 |
| 2 | Acenocoumarol 1 mg Tab | Acenocoumarol 1 mg Tab | 11,000 | no | consignee2dglp | 30 |
| 3 | TAB DIVALPROX 1000MG | TAB DIVALPROX 1000MG | 9,000 | no | consignee2dglp | 30 |
| 4 | Fluvoxamine 50 mg Cap | Fluvoxamine 50 mg Cap | 13,600 | no | consignee2dglp | 30 |
| 5 | Syrup Terbutaline sulphate 1 point 25 mg plus Bromhexine HCL 4 mg plus Guaiphenesin 50 mg per 5 ml bootle of 100 ml | Syrup Terbutaline sulphate 1 point 25 mg plus Bromhexine HCL 4 mg plus Guaiphenesin 50 mg per 5 ml bootle of 100 ml | 3,750 | no | consignee2dglp | 30 |
| 6 | Isosorbide Mononitrate 20 mg Tab | Isosorbide Mononitrate 20 mg Tab | 59,800 | no | consignee2dglp | 30 |
| 7 | Risperidone 4 mg Tab | Risperidone 4 mg Tab | 6,400 | no | consignee2dglp | 30 |
| 8 | Rivaroxaban 20 mg Tab | Rivaroxaban 20 mg Tab | 5,500 | no | consignee2dglp | 30 |
| 9 | Tacrolimus 0 point 5 mg Cap | Tacrolimus 0 point 5 mg Cap | 26,700 | no | consignee2dglp | 30 |
| 10 | Tab Methotrexate10 mg | Tab Methotrexate10 mg | 15,900 | no | consignee2dglp | 30 |
| 11 | Tab Melatonin 3 mg | Tab Melatonin 3 mg | 1,500 | no | consignee2dglp | 30 |
| 12 | Clobazam 5 mg Tab | Clobazam 5 mg Tab | 28,400 | no | consignee2dglp | 30 |
| 13 | Tab Donepezil 10mg | Tab Donepezil 10mg | 16,800 | no | consignee2dglp | 30 |
| 14 | Tab Dutasteride 0 point mg | Tab Dutasteride 0 point mg | 188,300 | no | consignee2dglp | 30 |
| 15 | Gabapentin 300 mg Cap | Gabapentin 300 mg Cap | 131,700 | no | consignee2dglp | 30 |
| 16 | Terbinafine 1 percentage cream Tube of 10 gm | Terbinafine 1 percentage cream Tube of 10 gm | 2,600 | tube | consignee2dglp | 30 |
| 17 | Nasal Decongestant adult drops Xylometazoline HCL 0 point 1 percentage w oblique v nasal drop bottle of 10 ml | Nasal Decongestant adult drops Xylometazoline HCL 0 point 1 percentage w oblique v nasal drop bottle of 10 ml | 2,850 | bott | consignee2dglp | 30 |
| 18 | Moxifloxacin Eye ointment 0 point 5 percentage w oblique w coma 5g | Moxifloxacin Eye ointment 0 point 5 percentage w oblique w coma 5g | 1,900 | tube | consignee2dglp | 30 |
| 19 | Tiotropium Bromide 9 mcg 120 metered doses oblique unit coma Inhaler | Tiotropium Bromide 9 mcg 120 metered doses oblique unit coma Inhaler | 4,200 | no | consignee2dglp | 30 |
| 20 | Tobramycin 0 point 3 percentage bott of 5 ml | Tobramycin 0 point 3 percentage bott of 5 ml | 370 | bott | consignee2dglp | 30 |
| 21 | Rifaximin 550mg Cap | Rifaximin 550mg Cap | 31,800 | no | consignee2dglp | 30 |
| 22 | Tab Bempedoic Acid 160 Mg | Tab Bempedoic Acid 160 Mg | 3,600 | no | consignee2dglp | 30 |
Discover companies most likely to bid on this tender
Start
18-May-2025, 1:00 pm
End
19-May-2025, 1:00 pm
Duration: 24 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
Key insights about WEST BENGAL tender market
The eligibility requirements include being a registered entity with the relevant regulatory bodies, holding valid licenses for pharmaceutical manufacture and distribution, and possessing prior experience in supplying pharmaceuticals to public sector clients. Additional financial and technical criteria must also be satisfied as per the tender documentation.
Bidder submissions must include certificates that validate product efficacy, quality assurance compliance, and health and safety standards. These documents must prove that the medications adhere to national and international pharmaceutical regulations to ensure a robust evaluation process.
Companies interested in participating must first register on the officially designated tender portal. The registration process usually requires submission of basic company details, licensing information, and compliance certifications necessary for the procurement of pharmaceutical products. Following this, bidders can access the tender documents and prepare their bids accordingly.
Documents must be submitted in the specified formats as outlined in the tender documents. Typically, electronic formats such as PDF or DOCX are preferred. Bidders should ensure that all submitted materials are clear, legible, and complete to avoid disqualification due to incomplete submissions.
The Earnest Money Deposit (EMD) is a prerequisite for bid consideration, meant to deter frivolous bids. Amounts and submission procedures are specified within the tender documentation. Bidders must ensure that their EMD is in place as failure to comply may lead to disqualification from the tender process.
Sign up now to access all documents
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS